DENIS CHEM LAB
|
DENIS CHEM LAB Last 5 Year Financial Ratios History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 8.04 | 5.66 | 4.51 | 1.63 | 3.04 |
| CEPS(Rs) | 13.04 | 11.30 | 8.66 | 5.93 | 7.84 |
| DPS(Rs) | 2.50 | 2.00 | 1.50 | 0.75 | - |
| Book NAV/Share(Rs) | 57.91 | 52.08 | 47.89 | 44.32 | 42.58 |
| Tax Rate(%) | 26.28 | 28.00 | 29.50 | 26.65 | 26.41 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 12.65 | 11.68 | 10.51 | 9.38 | 11.02 |
| EBIT Margin(%) | 9.34 | 7.19 | 7.06 | 4.25 | 6.33 |
| Pre Tax Margin(%) | 9.02 | 6.79 | 6.51 | 2.82 | 4.21 |
| PAT Margin (%) | 6.65 | 4.89 | 4.59 | 2.07 | 3.10 |
| Cash Profit Margin (%) | 10.79 | 9.75 | 8.80 | 7.52 | 7.99 |
| Performance Ratios | |||||
| ROA(%) | 10.69 | 8.03 | 6.64 | 2.39 | 4.15 |
| ROE(%) | 14.62 | 11.33 | 9.79 | 3.76 | 7.29 |
| ROCE(%) | 20.15 | 16.07 | 13.79 | 6.50 | 11.34 |
| Asset Turnover(x) | 1.61 | 1.64 | 1.45 | 1.15 | 1.34 |
| Sales/Fixed Asset(x) | 1.57 | 1.59 | 1.39 | 1.16 | 1.47 |
| Working Capital/Sales(x) | 3.98 | 4.57 | 4.88 | 4.66 | 8.69 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.64 | 0.63 | 0.72 | 0.87 | 0.68 |
| Receivable days | 68.40 | 71.57 | 86.49 | 113.29 | 95.09 |
| Inventory Days | 21.00 | 21.57 | 25.39 | 29.45 | 22.73 |
| Payable days | 83.39 | 82.06 | 89.23 | 111.66 | 104.74 |
| Valuation Parameters | |||||
| PER(x) | 18.76 | 11.26 | 15.10 | 22.89 | 9.76 |
| PCE(x) | 11.56 | 5.65 | 7.87 | 6.30 | 3.78 |
| Price/Book(x) | 2.60 | 1.22 | 1.42 | 0.84 | 0.70 |
| Yield(%) | 1.66 | 3.14 | 2.20 | 2.01 | - |
| EV/Net Sales(x) | 1.11 | 0.46 | 0.65 | 0.51 | 0.37 |
| EV/Core EBITDA(x) | 8.21 | 3.79 | 5.78 | 5.27 | 3.34 |
| EV/EBIT(x) | 11.85 | 6.36 | 9.23 | 12.05 | 5.92 |
| EV/CE(x) | 2.28 | 0.99 | 0.92 | 0.61 | 0.52 |
| M Cap / Sales | 1.25 | 0.55 | 0.69 | 0.47 | 0.30 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 4.34 | 17.79 | 24.92 | -19.71 | 9.68 |
| Core EBITDA Growth(%) | 16.77 | 25.82 | 45.27 | -30.65 | -1.60 |
| EBIT Growth(%) | 35.64 | 19.89 | 107.72 | -46.15 | -6.06 |
| PAT Growth(%) | 41.93 | 25.50 | 176.59 | -46.26 | -33.63 |
| EPS Growth(%) | 41.94 | 25.50 | 176.59 | -46.27 | -33.63 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.01 | 0.03 | 0.05 | 0.14 | 0.23 |
| Current Ratio(x) | 2.55 | 2.46 | 2.11 | 1.93 | 1.46 |
| Quick Ratio(x) | 2.18 | 2.08 | 1.72 | 1.57 | 1.21 |
| Interest Cover(x) | 28.86 | 18.02 | 12.74 | 2.99 | 2.98 |
| Total Debt/Mcap(x) | - | 0.02 | 0.03 | 0.17 | 0.33 |
Compare Financial Ratios of peers of DENIS CHEM LAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DENIS CHEM LAB | ₹138.2 Cr | 5.4% | 9.3% | -32.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,468.0 Cr | 3.4% | 2.2% | 13.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹156,319.0 Cr | 5.3% | 3.9% | 51.8% | Stock Analytics | |
| CIPLA | ₹122,075.0 Cr | 3.3% | 1.2% | 9.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹110,125.0 Cr | 4% | 6.3% | 29.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,227.9 Cr | 6.1% | 2.3% | -3.2% | Stock Analytics | |
DENIS CHEM LAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DENIS CHEM LAB | 5.4% |
9.3% |
-32.1% |
| SENSEX | 7.5% |
7.6% |
7% |
You may also like the below Video Courses
